REFERENCES
- Au W Y, Ma S K, Kwong Y L, Ng I O, Hawkins B R, Wan T S, Liu C L, Fan S T, Lo C M. Graft-versus-host disease after liver transplantation: Documentation by fluorescent in situ hybridisation and human leucocyte antigen typing.. Clin Transplant. 2000; 14: 174–177. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Karras A, Hermine O. [Hemophagocytic syndrome]. Rev Med Int. 2002; 23: 768–778
- Chisuwa H, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Oh-Ishi T, Hashikura Y, Hashikura Y, Kawasaki S. Fatal hemophagocytic syndrome after living-related liver transplantation: A report of two cases.. Transplantation. 2001; 72: 1843–1846. [PUBMED], [INFOTRIEVE]
- Wells A D, Hashikura Y, Turka L A. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response.. J Clin Invest. 1997; 100: 3173–3183. [PUBMED], [INFOTRIEVE]
- Wisecarver J L, Cattral M S, Langnas A N, Shaw B W, Jr., Fox I J, Heffron T G, Rubocki R J. Transfusion-induced graft-versus-host disease after liver transplantation. Documentation using polymerase chain reaction with HLA-DR sequence-specific primers.. Transplantation. 1994; 58: 269–271. [PUBMED], [INFOTRIEVE]
- Arrieta A, Hashikura Y, Hashikura Y, Fernandez J R, Ortiz de Hashikura Y, Garcia Masdevall M D. Confirmation of graft-versus-host disease by HLA typing after liver transplantation.. Transplant Proc. 2002; 34: 278–279. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Mazzaferro V, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Gennari L. Confirmation of graft-versus-host disease after liver transplantation by PCR HLA-typing.. Transplantation. 1993; 55: 423–425. [PUBMED], [INFOTRIEVE]
- Kiuchi T, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Tanaka K. One-way donor-recipient HLA-matching as a risk factor for graft-versus-host disease in living-related liver transplantation.. Transplant Int. 1998; 11: 383–384
- Akashi K, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, et al, Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults.. Br J Haematol. 1994; 87: 243–250. [PUBMED], [INFOTRIEVE]
- Imashuku S. Advances in the management of hemophagocytic lymphohistiocytosis.. Int J Hematol. 2000; 72: 1–11. [PUBMED], [INFOTRIEVE]
- Samuelsson-Henter J I, Horne A, Arico M, Egeler R M, Elinder G, Filipovich A H, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka G. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation.. Blood. 2002; 100: 2367–2373. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Imashuku S, Hashikura Y, Hashikura Y, Hibi S. Recent developments in the management of haemophagocytic lymphohistiocytosis.. Expert Opin Pharmacother. 2001; 2: 1437–1448. [PUBMED], [INFOTRIEVE]
- Rinon M, Hashikura Y, Hashikura Y, Fernandez J R, Ortiz de Hashikura Y, Garcia Masdevall M D. Selective immunosuppression with daclizumab in liver transplantation with graft-versus-host disease.. Transplant Proc. 2002; 34: 109–110. [PUBMED], [INFOTRIEVE]
- Lehner F, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Hashikura Y, Nashan B. Successful outcome of acute graft-versus-host disease in a liver allograft recipient by withdrawal of immunosuppression.. Transplantation. 2002; 73: 307–310. [PUBMED], [INFOTRIEVE]